Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

High-density lipoprotein subclasses in diabetes.

M Bergman, L I Gidez, H A Eder

    The American Journal of Medicine
    |September 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Sex differences in intestinal morphology and increase in diencephalic neuropeptide Y gene expression in female but not male Pekin ducks exposed to chronic heat stress.

    Journal of neuroendocrinology·2024
    Same author

    1-h post-load plasma glucose for detecting early stages of prediabetes.

    Diabetes & metabolism·2022
    Same author

    Bone mineral density, osteopenia and osteoporosis among US adults with cancer.

    QJM : monthly journal of the Association of Physicians·2022
    Same author

    Technique for modified transantral orbital decompression for improved cosmesis in stable thyroid eye disease.

    International journal of oral and maxillofacial surgery·2021
    Same author

    Use of 1-h post-load plasma glucose concentration to identify individuals at high risk of developing Type 2 diabetes.

    Diabetic medicine : a journal of the British Diabetic Association·2017
    Same author

    The yield of diagnostic work-up of patients presenting with myalgia, exercise intolerance, or fatigue: A prospective observational study.

    Neuromuscular disorders : NMD·2017
    Same journal

    Mineralocorticoid Antagonists for Post-MI HFpEF: Plausible Biology Meets Low Residual Risk?

    The American journal of medicine·2026
    Same journal

    GLP-1 Receptor Agonists and Age-related Macular Degeneration Risk in Diabetes or Non-diabetic Obesity: A Retrospective Cohort Study.

    The American journal of medicine·2026
    Same journal

    Marijuana Use and Acute Myocardial Infarction: Mechanistic Insights, Clinical Implications, and Emerging Challenges.

    The American journal of medicine·2026
    Same journal

    Cave Canem - Beware of the Dog.

    The American journal of medicine·2026
    Same journal

    Risk Factors for 30-day Hospital Readmission After Hospital-at-Home Treatment of Acute Pyelonephritis.

    The American journal of medicine·2026
    Same journal

    Mesenteric panniculitis.

    The American journal of medicine·2026
    See all related articles

    Insulin therapy improved high-density lipoprotein (HDL) cholesterol, particularly subclass 2, in diabetic patients. However, normalization was not achieved in all women, irrespective of diabetes control.

    Area of Science:

    • Endocrinology
    • Metabolic Disorders
    • Lipid Metabolism

    Background:

    • Diabetes mellitus is associated with altered lipid profiles.
    • High-density lipoprotein (HDL) cholesterol plays a crucial role in cardiovascular health.
    • Understanding HDL subclass dynamics in diabetes is vital for effective management.

    Purpose of the Study:

    • To evaluate the impact of diabetes treatments on HDL subclasses.
    • To investigate the relationship between HDL changes and metabolic control.
    • To assess the effect of insulin and oral hypoglycemic agents on HDL levels.

    Main Methods:

    • Cross-sectional study design.
    • Measurement of HDL subclasses using a precipitation technique.
    • Analysis of HDL levels before and after treatment in diabetic patients.

    Related Experiment Videos

    Main Results:

    • Untreated diabetes (types I and II) was linked to lower total HDL, primarily in subclass 2.
    • Insulin therapy increased total and subclass 2 HDL in both sexes and diabetes types.
    • HDL improvements with insulin were independent of metabolic control.
    • Normalization of HDL was not achieved in overweight women with type II diabetes and high triglycerides.
    • Oral hypoglycemic agents did not alter total or subclass 2 HDL levels.

    Conclusions:

    • Therapies targeting HDL predominantly affect subclass 2.
    • Insulin therapy enhances HDL levels but may not fully normalize them in certain patient groups.
    • Diabetes control does not correlate with changes in total and subclass 2 HDL.
    • Oral hypoglycemic agents do not negatively impact HDL levels.